University of Miami - 1120 NW 14th St — Miami, Florida

University of Miami - 1120 NW 14th St is a clinical research site located in Miami, Florida, United States 33136-2107.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of Miami - 1120 NW 14th St has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Developmental and Epileptic Encephalopathy.

Sponsors: Longboard Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Miami - 1120 NW 14th St?

University of Miami - 1120 NW 14th St has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Miami - 1120 NW 14th St conducted?

University of Miami - 1120 NW 14th St has 1 clinical trials on record, with 1 currently active. Their work covers Developmental and Epileptic Encephalopathy.

Is University of Miami - 1120 NW 14th St accredited by Crixeo Health?

University of Miami - 1120 NW 14th St has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Miami - 1120 NW 14th St?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.